- Research works
- 25 ▲ 606% vs 2013–17
- Citations
- 164 6.6 per fractional work
- Top-10% rate
- 13.3% record average 16.5%
- Open access
- 25% world 28%
Not ranked overall: Otsuka (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 26.1×. Every wedge is a field page.
Which keywords describe research at Otsuka (Germany)?
By fractional works in all years, weighted toward what it does more of than the world: Adverse Drug Reactions, Clinical Trials, Drug Development, Treatment, Off-Label Drug Use, Pediatric Pharmacokinetics, Genetics and Neurobiology.
- Neurocognitive Deficits
- Metabolic Syndrome
- Immune Response
- ADHD
- Pediatrics
- Meta-Analysis
- Diagnosis
- Epidemiology
- Pediatric Pharmacokinetics
- Treatment
- Clinical Trials
- Adverse Drug Reactions
- Drug Development
- Off-Label Drug Use
- Genetics
- Neurobiology
- Prevalence
- Community Health
- Drug Resistance
- Attention-Deficit/Hyperactivity Disorder
- Inflammation
- Antipsychotic Drugs
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 22 words, with their numbers
- Adverse Drug Reactions4▲ 239×3 topics
- Clinical Trials4▲ 24×4 topics
- Drug Development3▲ 98×2 topics
- Treatment3▲ 11×12 topics
- Off-Label Drug Use3▲ 337×1 topic
- Pediatric Pharmacokinetics3▲ 337×1 topic
- Genetics2▲ 12×6 topics
- Epidemiology2▲ 2.2×14 topics
- Neurobiology2▲ 23×3 topics
- Diagnosis2▲ 6.7×7 topics
- Prevalence2▲ 18×2 topics
- Meta-Analysis2▲ 11×2 topics
- Community Health1▲ 41×1 topic
- Pediatrics1▲ 134×1 topic
- Drug Resistance1▲ 16×3 topics
- ADHD1▲ 121×1 topic
- Attention-Deficit/Hyperactivity Disorder1▲ 121×1 topic
- Immune Response1▲ 7.7×5 topics
- Inflammation1▲ 1.98×6 topics
- Metabolic Syndrome1▲ 5.2×2 topics
- Antipsychotic Drugs1▲ 79×1 topic
- Neurocognitive Deficits1▲ 79×1 topic
Which research topics does Otsuka (Germany) publish most on?
By volume in 2022–2025: Tuberculosis Research and Epidemiology, Systemic Lupus Erythematosus Research, Genetic and Kidney Cyst Diseases and Renal Diseases and Glomerulopathies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Tuberculosis Research and Epidemiology Infectious Diseases 0 works
- 2 Systemic Lupus Erythematosus Research Rheumatology 0 works
- 3 Genetic and Kidney Cyst Diseases Genetics 0 works
- 4 Renal Diseases and Glomerulopathies Nephrology 0 works
- 5 Acute Myeloid Leukemia Research Hematology 0 works
- 6 Mycobacterium research and diagnosis Epidemiology 0 works
- 7 Digital Mental Health Interventions Applied Psychology 0 works
- 8 Mobile Health and mHealth Applications General Health Professions 0 works
- 9 Pharmacovigilance and Adverse Drug Reactions Toxicology 0 works
- 10 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Otsuka (Germany)'s research output changed?
Output in 2018–2022 was 606% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Munich
- Ludwig-Maximilians-Universität München
- Max Planck Society
- Technical University of Munich
- Siemens (Germany)
- München Klinik
- LMU Klinikum
- Munich University of Applied Sciences
- TUM Klinikum
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.